- 全部删除
- 您的购物车当前为空
GLPG3970 是一种新型可口服具有选择性的 SIK2/SIK3 双重抑制剂。GLPG3970 具有潜在的抗炎活性,可用于研究自身免疫性疾病。
为众多的药物研发团队赋能,
让新药发现更简单!
GLPG3970 是一种新型可口服具有选择性的 SIK2/SIK3 双重抑制剂。GLPG3970 具有潜在的抗炎活性,可用于研究自身免疫性疾病。
规格 | 价格 | 库存 | 数量 |
---|---|---|---|
1 mg | ¥ 413 | In stock | |
5 mg | ¥ 818 | In stock | |
10 mg | ¥ 1,230 | In stock | |
25 mg | ¥ 2,460 | In stock | |
50 mg | ¥ 3,690 | In stock | |
100 mg | ¥ 5,260 | In stock | |
200 mg | ¥ 7,190 | In stock | |
1 mL x 10 mM (in DMSO) | ¥ 891 | In stock |
GLPG3970 相关产品
产品描述 | GLPG3970 GLPG3970 is a novel orally available selective dual SIK2/SIK3 inhibitor.GLPG3970 has potential anti-inflammatory activity for the study of autoimmune diseases. |
靶点活性 | SIK3:3.8 nM, SIK2:7.8 nM, SIK1 cells:282.8 nM |
分子量 | 504.5 |
分子式 | C25H27F3N4O4 |
CAS No. | 2403733-82-2 |
Smiles | O=C1C=2C(OC)=CC(=CC2CCN1CC(F)(F)F)C3=CN=C4C=C(OCCN5CCOCC5)C=CN43 |
存储 | keep away from direct sunlight | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. | |||||||||||||||||||||||||||||||||||
溶解度信息 | DMSO: 80 mg/mL (158.57 mM), Sonication is recommended. | |||||||||||||||||||||||||||||||||||
溶液配制表 | ||||||||||||||||||||||||||||||||||||
DMSO
|
以上为“体内实验配液计算器”的使用方法举例,并不是具体某个化合物的推荐配制方式,请根据您的实验动物和给药方式选择适当的溶解方案。
评论内容